Clinical Trial

Effect of Olanzapine on Opioid Craving and Misuse Among Patients Receiving Opioids for Cancer-related Pain: A Pilot Double-Blind, Randomized Control Trial

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
To learn about the effectiveness of taking the antipsychotic medication olanzapine to help lower opioid craving.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2023-12-28; most recent amendment 2026-05-28.
Status change: Not Yet Recruiting → Recruiting 2024-04-02
Trial Details
NCT Number NCT06200181
Lead Sponsor M.D. Anderson Cancer Center
Conditions Misuse, Opioid
Enrollment 87 participants
Start Date 2024-04-02
Primary Completion 2026-11-01 (estimated)
Study Completion 2026-11-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-01